FreeTheAI

vTv Therapeutics, Inc. Class A

VTVT · NASDAQ · USD

$31.18

+1.10 3.66%todayNot financial advice.

VTVT Price chart 1M
Open
30.16
Day range
30.10 - 31.18
52-week range
19.50 - 44.00
Volume
12.84K
Market cap
123.29M
P/E ratio
—
EPS
-0.76
Dividend yield
0.00%
Beta
-0.67

Performance

W

−3.17%

1M

−5.49%

3M

−4.33%

6M

−16.43%

YTD

−22.32%

Y

+49.26%

5Y

−50.35%

All

−94.43%

In the news

  1. Oct 7

    vTv Therapeutics Receives FDA Orphan Drug Designation for Sickle Cell Disease Treatment

    vTv Therapeutics received FDA orphan drug status for its sickle cell candidate HPPD, helping advance partnership discussions for the program.

    Company news

  2. Oct 7

    vTv Therapeutics Receives FDA Orphan Drug Status for Sickle Cell Treatment

    vTv Therapeutics (NASDAQ:VTVT) received FDA orphan drug status for HPPD, a sickle cell disease candidate, boosting its partnering prospects.

    Company news

Embed on your site

Embed docs

Add a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.

<iframe src="https://stocks.freetheai.org/embed/NASDAQ-VTVT" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="vTv Therapeutics, Inc. Class A (VTVT) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-VTVT">VTVT stock price</a> by FreeTheAI Stocks</p>